Clinical characteristics and outcomes of dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid patients: A retrospective study

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American Academy of Dermatology 2024-10
Hauptverfasser:	Ujiie, Inkin, Katayama, Sho, Mai, Yosuke, Mai, Shoko, Yoshimoto, Norihiro, Muramatsu, Ken, Iwata, Hiroaki, Izumi, Kentaro, Ujiie, Hideyuki
Format:	Artikel
Sprache:	eng
Schlagworte:	anti-BP180NC16a antibody anti-full-length BP180 antibody bullous pemphigoid bullous pemphigoid disease area index clinical characteristics dipeptidyl peptidase-4 inhibitor
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title	Journal of the American Academy of Dermatology
container_volume
creator	Ujiie, Inkin Katayama, Sho Mai, Yosuke Mai, Shoko Yoshimoto, Norihiro Muramatsu, Ken Iwata, Hiroaki Izumi, Kentaro Ujiie, Hideyuki
description
doi_str_mv	10.1016/j.jaad.2024.09.067
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3120057699</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0190962224030330</els_id><sourcerecordid>3120057699</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1524-5fffb4081fb0fc235b736b8d93384f0e6c4704ad2fa8e599aa63cb5a0fabd7553</originalsourceid><addsrcrecordid>eNp9kUGO1DAQRS0EYpqBC7BAXrJJqDhOHCM2oxYwI43EBtaWY5dpt5I42M5IfQOOwVk4GW71wJJV1eL9r6r_CXndQN1A07871ketbc2A8RpkDb14QnYNSFH1YhBPyQ4aCZXsGbsiL1I6AoDkrXhOrlrJORsGviM_95NfvNETNQcdtckYfcreJKoXS8OWTZgx0eCo9Suu2dvTRC-LTlhx6peDH30OsdIpBeN1RkvHbZrClgo4rwf_PXhLV509Ljm9pze_f0XMMaQVTfYPSFPe7Okleeb0lPDV47wm3z59_Lq_re6_fL7b39xXpukYrzrn3MhhaNwIzrC2G0Xbj4OVbTtwB9gbLoBry5wesJNS6741Y6fB6dGKrmuvyduL7xrDjw1TVrNPBqdJL1hOVm3DADrRS1lQdkFNOTZFdGqNftbxpBpQ5wbUUZ0bUOcGFEhVGiiiN4_-2zij_Sf5G3kBPlwALF8-eIwqmZKMQetjCUTZ4P_n_wdQI5xQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3120057699</pqid></control><display><type>article</type><title>Clinical characteristics and outcomes of dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid patients: A retrospective study</title><source>Elsevier ScienceDirect Journals</source><creator>Ujiie, Inkin ; Katayama, Sho ; Mai, Yosuke ; Mai, Shoko ; Yoshimoto, Norihiro ; Muramatsu, Ken ; Iwata, Hiroaki ; Izumi, Kentaro ; Ujiie, Hideyuki</creator><creatorcontrib>Ujiie, Inkin ; Katayama, Sho ; Mai, Yosuke ; Mai, Shoko ; Yoshimoto, Norihiro ; Muramatsu, Ken ; Iwata, Hiroaki ; Izumi, Kentaro ; Ujiie, Hideyuki</creatorcontrib><identifier>ISSN: 0190-9622</identifier><identifier>ISSN: 1097-6787</identifier><identifier>EISSN: 1097-6787</identifier><identifier>DOI: 10.1016/j.jaad.2024.09.067</identifier><identifier>PMID: 39442884</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>anti-BP180NC16a antibody ; anti-full-length BP180 antibody ; bullous pemphigoid ; bullous pemphigoid disease area index ; clinical characteristics ; dipeptidyl peptidase-4 inhibitor</subject><ispartof>Journal of the American Academy of Dermatology, 2024-10</ispartof><rights>2024 American Academy of Dermatology, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1524-5fffb4081fb0fc235b736b8d93384f0e6c4704ad2fa8e599aa63cb5a0fabd7553</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0190962224030330$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39442884$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ujiie, Inkin</creatorcontrib><creatorcontrib>Katayama, Sho</creatorcontrib><creatorcontrib>Mai, Yosuke</creatorcontrib><creatorcontrib>Mai, Shoko</creatorcontrib><creatorcontrib>Yoshimoto, Norihiro</creatorcontrib><creatorcontrib>Muramatsu, Ken</creatorcontrib><creatorcontrib>Iwata, Hiroaki</creatorcontrib><creatorcontrib>Izumi, Kentaro</creatorcontrib><creatorcontrib>Ujiie, Hideyuki</creatorcontrib><title>Clinical characteristics and outcomes of dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid patients: A retrospective study</title><title>Journal of the American Academy of Dermatology</title><addtitle>J Am Acad Dermatol</addtitle><subject>anti-BP180NC16a antibody</subject><subject>anti-full-length BP180 antibody</subject><subject>bullous pemphigoid</subject><subject>bullous pemphigoid disease area index</subject><subject>clinical characteristics</subject><subject>dipeptidyl peptidase-4 inhibitor</subject><issn>0190-9622</issn><issn>1097-6787</issn><issn>1097-6787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kUGO1DAQRS0EYpqBC7BAXrJJqDhOHCM2oxYwI43EBtaWY5dpt5I42M5IfQOOwVk4GW71wJJV1eL9r6r_CXndQN1A07871ketbc2A8RpkDb14QnYNSFH1YhBPyQ4aCZXsGbsiL1I6AoDkrXhOrlrJORsGviM_95NfvNETNQcdtckYfcreJKoXS8OWTZgx0eCo9Suu2dvTRC-LTlhx6peDH30OsdIpBeN1RkvHbZrClgo4rwf_PXhLV509Ljm9pze_f0XMMaQVTfYPSFPe7Okleeb0lPDV47wm3z59_Lq_re6_fL7b39xXpukYrzrn3MhhaNwIzrC2G0Xbj4OVbTtwB9gbLoBry5wesJNS6741Y6fB6dGKrmuvyduL7xrDjw1TVrNPBqdJL1hOVm3DADrRS1lQdkFNOTZFdGqNftbxpBpQ5wbUUZ0bUOcGFEhVGiiiN4_-2zij_Sf5G3kBPlwALF8-eIwqmZKMQetjCUTZ4P_n_wdQI5xQ</recordid><startdate>20241021</startdate><enddate>20241021</enddate><creator>Ujiie, Inkin</creator><creator>Katayama, Sho</creator><creator>Mai, Yosuke</creator><creator>Mai, Shoko</creator><creator>Yoshimoto, Norihiro</creator><creator>Muramatsu, Ken</creator><creator>Iwata, Hiroaki</creator><creator>Izumi, Kentaro</creator><creator>Ujiie, Hideyuki</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20241021</creationdate><title>Clinical characteristics and outcomes of dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid patients: A retrospective study</title><author>Ujiie, Inkin ; Katayama, Sho ; Mai, Yosuke ; Mai, Shoko ; Yoshimoto, Norihiro ; Muramatsu, Ken ; Iwata, Hiroaki ; Izumi, Kentaro ; Ujiie, Hideyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1524-5fffb4081fb0fc235b736b8d93384f0e6c4704ad2fa8e599aa63cb5a0fabd7553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>anti-BP180NC16a antibody</topic><topic>anti-full-length BP180 antibody</topic><topic>bullous pemphigoid</topic><topic>bullous pemphigoid disease area index</topic><topic>clinical characteristics</topic><topic>dipeptidyl peptidase-4 inhibitor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ujiie, Inkin</creatorcontrib><creatorcontrib>Katayama, Sho</creatorcontrib><creatorcontrib>Mai, Yosuke</creatorcontrib><creatorcontrib>Mai, Shoko</creatorcontrib><creatorcontrib>Yoshimoto, Norihiro</creatorcontrib><creatorcontrib>Muramatsu, Ken</creatorcontrib><creatorcontrib>Iwata, Hiroaki</creatorcontrib><creatorcontrib>Izumi, Kentaro</creatorcontrib><creatorcontrib>Ujiie, Hideyuki</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Academy of Dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ujiie, Inkin</au><au>Katayama, Sho</au><au>Mai, Yosuke</au><au>Mai, Shoko</au><au>Yoshimoto, Norihiro</au><au>Muramatsu, Ken</au><au>Iwata, Hiroaki</au><au>Izumi, Kentaro</au><au>Ujiie, Hideyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical characteristics and outcomes of dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid patients: A retrospective study</atitle><jtitle>Journal of the American Academy of Dermatology</jtitle><addtitle>J Am Acad Dermatol</addtitle><date>2024-10-21</date><risdate>2024</risdate><issn>0190-9622</issn><issn>1097-6787</issn><eissn>1097-6787</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>39442884</pmid><doi>10.1016/j.jaad.2024.09.067</doi></addata></record>
fulltext	fulltext
identifier	ISSN: 0190-9622
ispartof	Journal of the American Academy of Dermatology, 2024-10
issn	0190-9622 1097-6787 1097-6787
language	eng
recordid	cdi_proquest_miscellaneous_3120057699
source	Elsevier ScienceDirect Journals
subjects	anti-BP180NC16a antibody anti-full-length BP180 antibody bullous pemphigoid bullous pemphigoid disease area index clinical characteristics dipeptidyl peptidase-4 inhibitor
title	Clinical characteristics and outcomes of dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid patients: A retrospective study
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T08%3A07%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20characteristics%20and%20outcomes%20of%20dipeptidyl%20peptidase-4%20inhibitor-associated%20bullous%20pemphigoid%20patients:%20A%C2%A0retrospective%20study&rft.jtitle=Journal%20of%20the%20American%20Academy%20of%20Dermatology&rft.au=Ujiie,%20Inkin&rft.date=2024-10-21&rft.issn=0190-9622&rft.eissn=1097-6787&rft_id=info:doi/10.1016/j.jaad.2024.09.067&rft_dat=%3Cproquest_cross%3E3120057699%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3120057699&rft_id=info:pmid/39442884&rft_els_id=S0190962224030330&rfr_iscdi=true